Related Experiment Videos
[Central anticholinergic syndrome after propofol anesthesia]
1Klinik für Anästhesiologie und Intensivmedizin, Universität des Saarlandes, Homburg/Saar.
Summary
A patient experienced central anticholinergic syndrome after propofol and alfentanil anesthesia. Physostigmine rapidly reversed the excitatory symptoms, highlighting its efficacy in treating this rare anesthesia complication.
Area of Science:
- Anesthesiology
- Neuroscience
- Pharmacology
Background:
- Vertebral disc prolapse surgery necessitates anesthesia.
- Anesthesia management involves careful drug selection and monitoring.
- Central anticholinergic syndrome is a rare but serious complication.
Observation:
- A 37-year-old patient underwent two anesthesia procedures within four weeks for vertebral disc prolapse.
- The first anesthesia used volatile agents without issue.
- The second anesthesia involved total intravenous anesthesia with propofol and alfentanil.
Findings:
- Following the second anesthesia, the patient exhibited the excitatory form of central anticholinergic syndrome.
- Intravenous administration of physostigmine led to immediate and complete resolution of the syndrome's symptoms.
Implications:
- This case underscores the potential for propofol and alfentanil to induce central anticholinergic syndrome.
- Physostigmine is an effective antidote for reversing anticholinergic toxicity in the context of anesthesia.
- Clinicians should maintain awareness of this syndrome and its treatment in patients receiving these anesthetic agents.